CHF Solutions was founded in July 1999 by Dr. Howard Levin and Mark Gelfand. On June 3, 2002, the company received marketing clearance from the U.S. Food and Drug Administration for its System 100 Fluid Removal System. CHF Solutions is a manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system. The Company's mission is to provide medical practitioners with innovative medical solutions that enable the treatment of patients with unmet clinical needs.